Transdermal Histamine in Multiple Sclerosis, Part Two: A Proposed Theoretical Basis for Its Use. Transdermal Histamine in Multiple Sclerosis, Part Two: A Proposed Theoretical Basis for Its Use.2018-01-17T17:01:47-05:00
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn’s Disease Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn’s Disease2018-01-17T17:01:47-05:00
History of modern multiple sclerosis therapy History of modern multiple sclerosis therapy2018-01-17T17:01:42-05:00
Additive effect of the combination of glatiramer acetate and minocycline in a model of MS Additive effect of the combination of glatiramer acetate and minocycline in a model of MS2018-01-17T17:01:35-05:00
Therapeutic Considerations for Disease Progression in Multiple Sclerosis Therapeutic Considerations for Disease Progression in Multiple Sclerosis2018-01-17T17:01:30-05:00
Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should Be Treated at the Time of Diagnosis Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should Be Treated at the Time of Diagnosis2018-01-17T17:01:24-05:00
Cholesterol drug counters MS symptoms in mice Cholesterol drug counters MS symptoms in mice2018-01-17T17:01:24-05:00
Fulminant liver failure during interferon beta treatment of multiple sclerosis Fulminant liver failure during interferon beta treatment of multiple sclerosis2018-01-17T17:01:24-05:00
